Law360, New York (February 10, 2014, 6:04 PM EST) -- A Jan. 27, 2014, decision by the California Court of Appeal is the latest contribution to the deepening judicial divide over preemption of state law tort claims in cases implicating Class III medical devices.
In Coleman v. Medtronic Inc., the California Court of Appeal held that the plaintiff's claims of negligence per se and strict liability failure to warn — based upon allegations that Medtronic violated federal regulations requiring it to submit adverse events reports to the U.S. Food and Drug Administration and prohibiting Medtronic from promoting its products for off-label use — were neither expressly preempted by the Medical Device...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!